Safety and Tolerability Study of Drug to Treat Schizophrenia
Completed · Phase 2
Conditions studied: Schizophrenia
In brief
The purpose of this study is to evaluate the long-term safety of SM-13496 in patients with schizophrenia.
Key facts
- Study ID
- NCT00044005
- Run by
- Sumitomo Pharma America, Inc.
- People needed
- 98
- Starts
- 2002-09-01
- Expected to finish
- 2003-11-01
- Last updated by the study team
- 2014-04-17
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Successful completion of participation in protocol #D1050049
You may not qualify if…
- Substance abuse
- Prolactin level of ≥200ng/mL at baseline
- Pregnancy
Where it is running
- Birmingham Psychiatry Pharmaceutical — Birmingham, Alabama, United States
- Institute for Psychopharmacology Research — Cerritos, California, United States
- CNS Network — Garden Grove, California, United States
- California Clinical Trials Medical Group — Glendale, California, United States
- Optimum Health Services — La Mesa, California, United States
- University of California, Irvine — Orange, California, United States
- California Neuropsychopharmacology Clinical Research Institute — San Diego, California, United States
- Psychiatric Institute of Washington — Washington D.C., District of Columbia, United States
- Comprehensive Neuroscience. Inc. — Melbourne, Florida, United States
- Segal Institute for Clinical Research — North Miami, Florida, United States
- University of South Florida — Tampa, Florida, United States
- Coordinated Research of Florida, Inc — Winter Park, Florida, United States
- Hawaii Research Center — Honolulu, Hawaii, United States
- Alexian Brothers Behavioral Health Hospital — Hoffman Estates, Illinois, United States
- American Medical Research — Oak Brook, Illinois, United States
- Lake Mead Hospital — North Las Vegas, Nevada, United States
- Comprehensive Clinical Research, CNS — Clementon, New Jersey, United States
- ClinSearch, Inc. — Kenilworth, New Jersey, United States
- Quantum Clinical Services Group — Philadelphia, Pennsylvania, United States
- Albert Einstein Medical Center — Philadelphia, Pennsylvania, United States
- Community Clinical Research — Austin, Texas, United States
- FutureSearch Trials — Austin, Texas, United States
- Claghorn Lesem Research Clinic, Inc. — Bellaire, Texas, United States
- St. Paul Medical Center — Dallas, Texas, United States
- CNS, Inc. — Falls Church, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.